Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
about
Olanzapine versus other atypical antipsychotics for schizophreniaAmisulpride versus other atypical antipsychotics for schizophreniaThe effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label studyWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Response to: A Commentary on "Antipsychotic-Induced Parkinsonism is Associated with Working Memory Deficits in Schizophrenia-Spectrum Disorders"Olanzapine: a critical review of recent literature.Current schizophrenia drugs: efficacy and side effects.Evaluation of efficacy, safety, and cognitive profile of amisulpride per se and its comparison with olanzapine in newly diagnosed schizophrenic patients in an 8-week, double-blind, single-centre, prospective clinical trial.Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administrationTranslating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What's the Evidence?Update on the management of symptoms in schizophrenia: focus on amisulpride.Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials.Effects of amisulpride on the cognitive function of patients with schizophrenia who switched from risperidone.Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics.Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
P2860
Q24236545-2E00A5E0-4AD3-45ED-A621-CC911B67A0A7Q24240433-C8A8CE0B-4DB8-4FF8-8402-C8A13BCDB1F2Q24800019-E0A2151E-A56F-4911-9C11-5EC13F59DCAEQ34640811-D65490A9-5467-4A68-8413-A06445FCD089Q35941992-77D6FE07-4636-493B-9F2D-1CA5DCF8291BQ36273449-35E93F9D-76D6-456D-8F05-A988C0114584Q36488206-0A706C60-4F80-4458-9B97-D07ADA55FF20Q36858373-6515AA2D-3C84-4D35-A4F8-C991425BDBAAQ36969243-49168084-570E-4677-AA5F-B228472B24F5Q38149953-17E2672A-40F5-402A-8E2C-5F1ABA134DA4Q38173359-4E00CDCA-BE13-4930-B81A-D422DFE81F16Q41529086-EEE1BCD6-5BAC-44DF-8546-1D7202481E16Q41569283-5AB92A8E-7A57-4135-AB41-4E4116709EC2Q51968316-AEB7E1B5-B1C8-40D6-880A-2D44AD13569FQ51980548-F0CE9738-485F-4CFF-9811-8EA9844706DBQ58763260-1909B8EF-0657-4BF8-B20A-CCE4B081A0A8
P2860
Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@en
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@nl
type
label
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@en
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@nl
prefLabel
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@en
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@nl
P2093
P2860
P50
P356
P1476
Cognitive improvement in schiz ...... of olanzapine vs amisulpride.
@en
P2093
Jens Westheide
Kai-Uwe Kühn
Wolfgang Maier
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300626
P407
P577
2005-02-01T00:00:00Z
P5875
P6179
1051630383